Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
AT-003 by Arctic Therapeutics ehf for Multiple Sclerosis: Likelihood of Approval
AT-003 is under clinical development by Arctic Therapeutics ehf and currently in Phase II for Multiple Sclerosis. According to GlobalData,...
AT-003 by Arctic Therapeutics ehf for Parkinson's Disease: Likelihood of Approval
AT-003 is under clinical development by Arctic Therapeutics ehf and currently in Phase II for Parkinson's Disease. According to GlobalData,...
AT-003 by Arctic Therapeutics ehf for Rheumatoid Arthritis: Likelihood of Approval
AT-003 is under clinical development by Arctic Therapeutics ehf and currently in Phase II for Rheumatoid Arthritis. According to GlobalData,...
AT-003 by Arctic Therapeutics ehf for Systemic Lupus Erythematosus: Likelihood of Approval
AT-003 is under clinical development by Arctic Therapeutics ehf and currently in Phase II for Systemic Lupus Erythematosus. According to...